The data was revealed on Wednesday by the Russian Direct Investment Fund (RDIF), the sovereign wealth fund which bankrolled the…
The results of the large-scale research by the Ministry of Health of the City of Buenos Aires were published in…
The results of second-phase trials of the vaccine, known as R21 / Matrix-M and developed by the University of Oxford…
On Monday, the pharmaceutical giant released promising interim results from its US study, which showed its drug to have 79%…
The scientists pointed to data from a study published in the Lancet last month that found the British-Swedish vaccine had…
In a statement, Moscow's Gamaleya Institute and Russian Direct Investment Fund (RDIF), which funded the vaccine’s development, cited data received…
On Monday, the pharmacological company announced that its AZD1222 vaccine for Covid-19, which is based on a common cold virus…
The Lancet, the New England Journal of Medicine, and the American Medical Association Journal all turned down the paper, Danish…